A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction by Helgadottir Anna, Manolescu Andrei, Helgason Agnar, Thorleifsson Gudmar, Thorsteinsdottir Unnur, Gudbjartsson Daniel F, Gretarsdottir Solveig, Magnusson Kristinn P, Gudmundsson Gudmundur, Hicks Andrew, Jonsson Thorlakur, Grant Struan F A, Sainz Jesus, O'Brien Stephen J, Sveinbjornsdottir Sigurlaug, Valdimarsson Einar M, Matthiasson Stefan E, Levey Allan I, Abramson Jerome L, Reilly Murdach P, Vaccarino Viola, Wolfe Megan L, Gudnason Vilmundur, Quyyumi Arshed A, Topol Eric J, Rader Daniel J, Thorgeirsson Gudmundur, Gulcher Jeffrey R, Hakonarson Hakon, Kong Augustine, Stefansson Kari in Nature genetics (2006).

[PMID: 16282974] PubMed


Variants of the gene ALOX5AP (also known as FLAP) encoding arachidonate 5-lipoxygenase activating protein are known to be associated with risk of myocardial infarction. Here we show that a haplotype (HapK) spanning the LTA4H gene encoding leukotriene A4 hydrolase, a protein in the same biochemical pathway as ALOX5AP, confers modest risk of myocardial infarction in an Icelandic cohort. Measurements of leukotriene B4 (LTB4) production suggest that this risk is mediated through upregulation of the leukotriene pathway. Three cohorts from the United States also show that HapK confers a modest relative risk (1.16) in European Americans, but it confers a threefold larger risk in African Americans. About 27% of the European American controls carried at least one copy of HapK, as compared with only 6% of African American controls. Our analyses indicate that HapK is very rare in Africa and that its occurrence in African Americans is due to European admixture. Interactions with other genetic or environmental risk factors that are more common in African Americans are likely to account for the greater relative risk conferred by HapK in this group.

[ hide abstract ]

Discussed In Paper


Rx Annotations

No dosing information annotated.